Originally a biotechnologist and EEC researcher, Gary has spent 16 years in pharmaceutical sales, marketing and research and been involved in multiple drug launches.
He has spent 15 years working in medical aesthetics and was pivotal in the acquisition of PLLA at Sanofi-Aventis where he was head of medical aesthetics. He developed and executed the launch and scaling strategies prior to the business being sold to Valeant.
Gary co-founded 5 Squirrels Ltd in 2014, a start-up company which supports healthcare professionals working in medical aesthetics to build their brands, increase patient recruitment and retention with a novel approach to launching their own brand skincare products. The company has launched over 150 skincare brands internationally.